Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3

CPC - классификация

AA6A61A61KA61K3A61K39A61K39/A61K39/3A61K39/39A61K39/395A61K39/3955A61K39/39558A61PA61P3A61P35A61P35/A61P35/0A61P35/00A61P35/04CC0C07C07KC07K1C07K16C07K16/C07K16/2C07K16/28C07K16/280C07K16/2809C07K16/286C07K16/2863C07K2C07K23C07K231C07K2317C07K2317/C07K2317/3C07K2317/31C07K2317/6C07K2317/62C07K2317/622C07K2317/7C07K2317/73C07K2317/9C07K2317/94

IPC - классификация

AA6A61A61KA61K3A61K39A61K39/A61K39/3A61K39/39A61K39/395A61PA61P3A61P35A61P35/A61P35/0A61P35/02A61P35/04CC0C07C07KC07K1C07K16C07K16/C07K16/2C07K16/28

Цитирование НПИ

Altschul et al., Basic local alignment tool, J. Mol. Biol. 215: 403-10 (1990).
Altschul et al., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucl. Acids Res. 25(17): 3389-402 (1997).
Altschul et al., Local alignment statistics, Meth. Enzymol. 266: 460-80 (1996).
Andersen et al., Extending serum half-life of albumin by engineering FcRn binding. J. Biol. Chem. 289(19): 13492-502 (2014).
Aplin et al., Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids, CRC Crit. Rev. Biochem. 259-306 (1981).
Arakawa et al., Solvent interactions in pharmaceutical formulations, Pharm. Res. 8(3): 285-91 (1991).
Artsaenko et al., The expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco, The Plant J. 8: 745-50 (1995).
Beatty et al., Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies, Cancer Immunol Res. 1;2(2): 112-20 (2014).
Beckman et al., Antibody constructs in cancer therapy, Cancer. 109(2): 170-79 (2007).
Bird et al., Single-chain antigen-binding proteins, Science. 242: 423-26 (1988).
Bruühl et al., Depletion of CCRS-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV, Immunol. 166: 2420-6 (2001).
Carter et al., High level Escherichia coli expression and production of a bivalent humanized antibody fragment, Biotechnology. 10:163-7 (1992).
Chalfie et al., Green fluorescent protein as a marker for gene expression, Science. 263: 802-5 (1994).
Chang et al., Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers, Proc. Natl. Acad. Sci. USA. 93(1): 136-40 (1996).
Cheadle et al., Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: recovery of active FV fragments, Mol. Immunol. 29: 21-30 (1992).
Cheson et al., Report of an international workshop to standardize response criteria for Non-Hodgkin's Lymphomas, J. Clin. Oncol. 17(4): 1244-53 (1999).
Choi et al., Systemic administration of a bispecific antibody targeting EGFRvIII sucessfully treats intracerebral glioma, Proc. Natl. Acad. Sci. USA. 110(1): 270-75 (2013).
Chothia et al., Canonical structures for the hypervariable regions of immunoglobulins, J. Mol. Biol. 196: 901-17 (1987).
Chothia et al., Conformation of immunoglobulin hypervariable regions, Nature. 342: 877-83 (1989).
Clackson et al., Making antibody fragments using phage display libraries, Lett. Nature. 352: 624-8 (1991).
Cook et al., The human immunoglobulin VH repertoire, Immunol. Today. 16(5): 237-42 (1995).
Cunningham et al., High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis, Science. 244: 1081-5 (1989).
Dall'Acqua et al., Contribution of domain interface residues to the stability of antibody CH3 domain homodimers, Biochemistry. 37: 9266-73 (1998).
Devereux et al., A comprehensive set of sequence analysis programs for the VAX, Nucl. Acid. Res. 12: 387-95 (1984).
Durben et al., Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia, Molecular Therapy. 23: 648-655 (2015).
Duskin et al., Relationship of the structure and biological activity of the natural homologues of tunicamycin, J. Biol. Chem. 257(6): 3105-9 (1982).
Edge et al., Deglycosylation of glycoproteins by trifluoromethanesulfonic acid, Anal. Biochem. 118: 131-7 (1981).
Emlet et al., Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III, Cancer Res. 74(4): 1238-49 (2014).
Eppstein et al., Biological activity of liposome-encapsulated murine interferon γ is mediated by a cell membrane receptor, Proc. Natl. Acad. Sci. USA. 82: 3688-92 (1985).
Fanslow et al., Structural characteristics of CD40 ligand that determine biological function, Semin. Immunol. 6: 267-78 (1994).
Fecker et al., Expression of single-chain antibody fragments (scFv) specific for beet necrotic yellow vein virus coat protein or 25 kDa protein in Escherichia coli and Nicotiana benthamiana, Plant Mol. Biol. 32: 979-86 (1996).
Feng et al., Progressive sequence alignment as a prerequisite to correct phylogenetic trees, J. Mol. Evol. 35: 351-60 (1987).
Fujimori et al., A modeling analysis of monoclonal antibody percolation through tumors: A binding-site barrier, J. Nuc. Med. 31(7): 1191-98 (1990).
Gabizon et al., Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times, J. National Cancer Inst. 81(19): 1484-8 (1989).
Garcia de Palazzo et al., Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas, Cancer Res. 53(14): 3217-20 (1993).
Ge et al., Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis, Int. J. Cancer. 98(3): 357-61 (2002).
Graham et al., Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. Gen. Virol. 36: 59-74 (1977).
Green et al., Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs, Nat. Genet. 7: 13-21 (1994).
Green et al., Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes, J. Exp. Med. 188: 483-95 (1998).
Gussow et al., Humanization of monoclonal antibodies, Methods in Enzymology. 203: 99-121 (1991).
Hakimuddin et al., A chemical method for the deglycosylation of proteins, Arch. Biochem. Biophys. 259: 52-7 (1987).
Hawkins et al., Selection of phage antibodies by binding affinity, J. Mol. Biol. 254: 889-96 (1992).
Hay et al., Clinical development success rates for investigational drugs, Nature Biotechnology. 32(1): 40-51 (2014).
Heim et al., Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer, Curr. Biol. 6: 178-82 (1996).
Hiatt et al., Production of antibodies in transgenic plants, Nature. 342: 76-8 (1989).
Higgins et al., Fast and sensitive multiple sequence alignments on a microcomputer, CABIOS. 5: 151-3 (1989).
Hoffmann et al., Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia, Leukemia. 26: 1228-1237 (2012).
Holliger et al., “Diabodies”: small bivalent and bispecific antibody fragments, Proc. Natl. Acad. Sci. USA. 90(14): 6444-8 (1993).
Holt et al., Domain antibodies: proteins for therapy, Trends in Biotech. 21(11):484-89 (2003).
Hoppe et al., A parallel three stranded alpha-helical bundle at the nucleation site of collagen triple-helix formation, FEBS Lett. 344: 191-5 (1994).
Huston et al., Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli, Proc. Natl. Acad. Sci. USA. 85: 5879-83 (1988).
Hwang et al., Hepatic uptake and degradation of unilamellar sphingomyelin/cholecterol liposomes: A kinetic study, Proc. Natl. Acad. Sci. USA. 77: 4030-4 (1980).
Hwang et al., Use of human germline genes in a CDR homology-based approach to antibody humanization, Methods. 36(1): 35-42 (2005).
Ichiki et al., Regulation of the expression of human C epsilon germline transcript. Identification of a novel IL-4 responsive element, J. Immunol. 150: 5408-17 (1993).
International Search Report and Written Opinion corresponding to International Application No. PCT/EP2016/068304, dated Nov. 29, 2016.
International Search Report and Written Opinion corresponding to International Application No. PCT/EP2016/068319, dated Nov. 23, 2016.
International Search Report and Written Opinion corresponding to International Application No. PCT/EP2016/068332, dated Nov. 28, 2016.
International Search Report and Written Opinion corresponding to International Application No. PCT/EP2017/052212, dated Jul. 4, 2017.
Jones et al., Replacing the complementarity-determine regions in a human antibody with those from a mouse, Nature. 321: 522-5 (1986).
Jubala et al., CD20 expression in normal canine B cells and in canine non hodgkin-lymphoma, Vet Pathol. 42: 468-76 (2005).
Karlin et al., Applications and statistics for multiple high-scoring segments in molecular sequences, Proc. Natl. Acad. Sci. USA. 90: 5873-7 (1993).
Kaufman, Selection and coamplification of heterologous genes in mammalian cells, Meth. Enzymol. 185: 537-66 (1990).
Kendrick et al., Physical stabilization of proteins in aqueous solution, in: Rational design of stable protein formulations: theory and practice. Carpenter and Manning (eds.), Pharmaceutical Biotechnology. 13: 61-84 (2002).
Kipriyanov et al., Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics, J. Mol. Biol. 293: 41-56 (1999).
Knappe et al., Herpesvirus saimiri-transformed macaque T cells are tolerated and do not cause lymphoma after autologous reinfusion, Blood. 95(10): 3256-61 (2000).
Kohler et al., Continuous cultures of fused cells secreting antibody of predefined specificity, Nature. 256:495-7 (1975).
Kozbor et al., The production of monoclonal antibodies from human lymphocytes, Immunol. Today. 4(3): 72-9 (1983).
Kufer et al., A revival of bispecific antibodies, Trends Biotechnol. 22(5): 238-44 (2004).
Kufer et al., Construction and biological activity of a recombinant bispecific single-chain antibody designed for therapy of minimal residual colorectal cancer, Cancer Immunol. Immunother. 45: 193-7 (1997).
Landschulz et al., The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins, Science 240: 1759-64 (1988).
Langer et al., Biocompatibility of polymeric delivery systems for macromolecules, J. Biomed. Mater. Res. 15(2): 267-77 (1981).
Langer, Controlled release of macromolecules, Chem. Tech. 12: 98-105 (1982).
Lippincott-Schwartz, Antibodies as call biological tools, Current Protocols in Cell Biology. 16.0.1-16.0.2 (2002).
Lowman et al., Selecting high-affinity binding proteins by monovalent phage display, Biochemistry. 30: 10832-7 (1991).
Löffler et al., A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes, Blood. 95(6): 2098-103 (2000).
MacCallum et al., Antibody-antigen intractions: Contact analysis and binding site technology, J. Mol. Biol. 262: 732-45 (1996).
Mack et al., A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity, Proc. Natl. Acad. Sci. USA. 92(15): 7021-5 (1995).
Mack et al., Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity, J. Immunol. 158: 3965-70 (1997).
Malmborg et al., BIAcore as a tool in antibody engineering, J. Immunol. Meth. 183: 7-13 (1995).
Marks et al., By-passing immunization: Human antibodies from V-gene libraries displayed on phage, J. Mol. Biol. 222:581-97 (1991).
Martin et al., Irreversible coupling of immunoglobulin fragments to preformed vesicles, J. Biol. Chem. 257: 286-8 (1982).
Martin et al., Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies, J. Mol. Biol. 263: 800-15 (1996).
Mather et al., Culture of testicular cells in hormone-supplemented serum-free medium, Ann. N.Y. Acad. Sci. 383: 44-68 (1982).
Mather, Establishment and characterization of two distinct mouse testicular epithelial cell lines, Biol. Reprod. 23: 243-51 (1980).
Mendez et al., Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice, Nat. Genet. 15: 146-56 (1997).
Morrison et al., Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, Proc. Natl. Acad. Sci. USA. 81: 6851-5 (1984).
Morrison et al., Combinatorial alanine-scanning, Curr. Opin. Chem. Biol. 5(3): 302-7 (2001).
Morrison, Transfectomas provide novel chimeric antibodies, Science. 229(4719): 1202-7 (1985).
Moscatello et al., Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors, Cancer Res. 55(23): 5536-9 (1995).
Needleman et al., A general method applicable to the search for similarities in the amino acid sequence of two proteins, J. Mol. Biol. 48: 443-53 (1970).
Nolan et al., Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ, Proc. Natl. Acad. Sci. USA. 85: 2603-7 (1988).
Olapade-Olaopa et al., Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer, Br. J. Cancer. 82(1): 186-94 (2000).
Olsson et al., Human-human monoclonal antibody-producing hybridomas: Technical aspects, Meth. Enzymol. 92: 3-16 (1982).
Owen et al., Synthesis of a functional anti-phytochrome single-chain Fv protein in transgenic tobacco, Bio/Technology. 10: 790-4 (1992).
Padlan, Anatomy of the antibody molecule, Molec. Immunol. 31(3): 169-217 (1993).
Pearson et al., Improved tools for biological sequence comparison, Proc. Natl. Acad. Sci. USA. 85:2444-8 (1988).
Presta, Antibody engineering, Curr. Op. Struct. Biol. 2: 593-6 (1992).
Raag et al., Single-chain Fvs, FASEB J. 9(1): 73-80 (1995).
Randolph et al., Surfactant-protein interactions, Pharm Biotechnol. 13: 159-75 (2002).
Raum et al., Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens, Cancer Immunol. Immunother. 50: 141-50 (2001).
Riechmann et al., Reshaping human antibodies for therapy, Nature. 332: 323-9 (1988).
Rouet et al., Fully human VH single domains that rival the stability and cleft recognition of camelid antibodies, J. Biol. Chem. 290(19): 11905-17 (2015).
Rudikoff et al., Single amino acid substitution altering antigen-binding specificity, Proc. Natl. Acad. Sci. USA. 79: 1979-1983 (1982).
Rudnick et al., Affinity and avidity in antibody-based tumor targeting, Cancer Biotherapy and Radio Pharmaceuticals. 24(2): 155-61 (2009).
Schier et al., Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections, Hum. Antibodies Hybridomas. 7(3): 97-105 (1996).
Schlereth et al., T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct, Cancer Immunol. Immunother. 55: 503-14 (2006).
Sidman et al., Controlled release of macromolecules and pharmaceuticals from synthetic polypeptides based on glutamic acid, Biopolymers. 2: 547-56 (1983).
Skerra et al., Assembly of a functional immunoglobulin Fv fragment in Escherichia coli, Science. 242: 1038-41 (1988).
Smith et al., Comparison of biosequences, Adv. Appl. Math. 2: 482-9 (1981).
Smith, Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface, Science. 228: 1315-7 (1985).
Songsivilai et al., Bispecific antibody: a tool for diagnosis and treatment of disease, Clin. Exp. Immunol. 79: 315-21 (1990).
Stauber et al., Development and applications of enhanced green fluorescent protein mutants, Biotechniques. 24: 462-71 (1998).
Takeda et al., Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences, Nature. 314: 452-4 (1985).
Teng et al., Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production, Proc. Natl. Acad. Sci. USA. 80: 7308-12 (1983).
Thotakura et al., Enzymatic deglycosylation of glycoproteins, Meth. Enzymol. 138: 350-9 (1987).
Thurber et al., Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance, Adv. Drug Deliv. Rev. 60: 1421-34 (2008).
Tomlinson et al., The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops, J. Mol. Biol. 227: 776-98 (1992).
Tomlinson et al., The structural repertoire of the human V kappa domain, EMBO J. 14: 4628-38 (1995).
Urlaub et al., Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity, Proc. Natl. Acad. Sci. USA. 77: 4216-20 (1980).
Ward et al., Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli, Lett. Nature. 341: 544-6 (1989).
Wikstrand et al., Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas, Cancer Res. 55(14): 3140-8 (1995).
Wu et al., Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues, J. Mol. Biol. 294: 151-62 (1999).
Yuan et al., A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma, Journal of Hematology and Oncology. 7:1-14 (2014).